Phase two of trials for a Russian-made coronavirus vaccine will end on August 3, to be immediately followed by a third, international phase. If successful, it could be the first effective Covid-19 solution to be mass-produced.
The vaccine, which has been developed by Moscow’s Gamalei Institute of Epidemiology in conjunction with the Ministry of Defense, will soon begin clinical trials abroad.
Continue reading https://on.rt.com/alw8